Prelude Capital Management, LLC Merck & Co., Inc. Call Options Transaction History

Prelude Capital Management, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $292,215 - $331,240	-3,500 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $279,338 - $313,120	-3,800 Reduced 52.05%	3,500 $287,000
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $527,644 - $660,942	7,300 New	7,300 $559,000
Q2 2021 Aug 16, 2021	SELL	$70.31 - $77.77 $435,922 - $482,174	-6,200 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$68.86 - $81.11 $420,046 - $494,771	6,100 Added 6100.0%	6,200 $478,000

Q3 2020 Nov 16, 2020	SELL	$73.18 - $82.95 $1.05 Million - $1.19 Million	-14,300 Reduced 99.31%	100 $8,000
Q2 2018 Aug 14, 2018	BUY	$50.83 - $59.72 $731,952 - $859,968	14,400 New	14,400 $874,000

3,767

1.87B

17.3M

14.8M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $324B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.